Atlanta TV station severs ties with fired radio hosts, station over Gleason skit
POSTED: Wednesday, June 19, 2013 - 3:00pm
UPDATED: Wednesday, June 19, 2013 - 3:04pm
NEW ORLEANS, LA (WDSU-CNN) — After three Atlanta radio hosts aired a segment in which they mocked former Saint and ALS patient Steve Gleason, a network affiliate in Georgia has severed ties with the radio station.
Not only were Nick Cellini, Steve “Steak” Shapiro and Chris Dimino fired from 790 The Zone, but their horribly unfunny skit lead CBS Atlanta to terminate its arrangement with the radio station, according to Access Atlanta.
Cellini, Shapiro and Dimino, were involved in the segment in which Cellini played Gleason with a robotic voice in a fake phone interview on 790 The Zone’s “Mayhem in the AM.”
Amyotrophic lateral sclerosis, ALS, is a disease that strips victims of their abilities, including speech and motor skills. As a result, Gleason now communicates via a computer.
Access Atlanta reports that Trey Fabacher, the general manager, said Cellini, Shapiro and Dimino were the primary talent on the hour-long weekly Saturday evening program “CBS Atlanta Sportsline.” The show aired at 7:00 p.m.
CBS Atlanta said in a statement sent out to local media that "Sportsline" will be on hiatus until the football season starts. New hosts will be hired for the program when it returns.
"Our employees, our partners and sponsors in no way support the content that was aired by this radio team on Monday morning,” CBS said in the statement.
The trio apologized via their respective social media accounts on Twitter and Facebook and even went as far to contact Gleason and apologize to him and his family. Gleason said he accepts the apology.
"The DJs have provided genuine apology. Received and accepted. We have all made mistakes in this life. How we learn from our mistakes is the measure of who we are," Gleason said.
Gleason said he and the Team Gleason Foundation hope to turn the negative into a positive by creating more awareness about the rare disease and raising money to help find a cure.